Troponin T is a strong marker of mortality in hospitalized patients

Kasper Iversen1, Lars Køber, Jens Peter Gøtze

  • 1Department of Cardiology, Rigshospitalet, Copenhagen, Denmark; Department of Cardiology and Endocrinology, Hillerød Hospital, Hillerød, Denmark.

Insights

Elevated high-sensitivity troponin T (hs-TnT) is common in hospitalized older adults, affecting over half the cohort. This finding indicates that hs-TnT is a significant predictor of mortality risk in this population.

Area of Science:

  • Cardiology
  • Clinical Diagnostics
  • Biomarker Research

Background:

  • Cardiac troponins are established markers for acute coronary syndrome and stable coronary disease.
  • The prevalence and prognostic significance of elevated troponin in the general hospitalized population are not well-defined.

Purpose of the Study:

  • To investigate the prevalence of elevated high-sensitivity troponin T (hs-TnT) in a general hospitalized population.
  • To determine the prognostic value of hs-TnT levels for mortality risk in these patients.

Main Methods:

  • A cohort of 1176 patients over 40 years old admitted to a district hospital was studied.
  • hs-TnT was measured using a high-sensitivity assay, alongside echocardiography and natriuretic peptides.
  • Follow-up data was collected for a median of 11.4 years.

Main Results:

  • Over half (57.1%) of the hospitalized patients had elevated hs-TnT levels (> 99th percentile).
  • Elevated hs-TnT (above median) was associated with a 3-fold higher mortality risk.
  • In patients without ischemic heart disease, hs-TnT in the upper quartile significantly increased mortality risk (HR 1.8-2.2).

Conclusions:

  • A high prevalence of elevated hs-TnT was observed in general hospitalized older patients.
  • Elevated hs-TnT serves as a potent marker for increased mortality risk in this demographic.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...